{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:025d90a8-f941-4960-9a33-3393bec9d167","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-10T08:08:16.7805+00:00","published_at":"2026-10-10T04:46:27.563543+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1ympfwk1uk9kiu","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-17","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:charles-ence","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:da10177ac844caba4a7ef1adc8517579bb4f447c23e96a99b23e87d9745ab222"],"summary":"Charles Ence executive of RELMADA THERAPEUTICS, INC., effective 2026-04-17.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:xst4leed8qi2","event_type":"CFO_CHANGED","effective_at":"2026-04-17","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:maged-shenouda","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:dd640bb3c5618fe2124057cc303ea5743926d4c5c17312f35d8d833b97db09fa"],"summary":"Maged Shenouda executive of RELMADA THERAPEUTICS, INC., effective 2026-04-17.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wppyot1gbzsql","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-17","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:paul-kelly","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:9e778f6380b0cfe1a78b89f06f2795aa611d6032b15bc830298cbc9784ac5727"],"summary":"Paul Kelly executive of RELMADA THERAPEUTICS, INC., effective 2026-04-17.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:tn7yff20wyj5","event_type":"CEO_CHANGED","effective_at":"2026-04-17","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:sergio-traversa","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:83d65013329955c9526ec0a0893e4c83a77ef3aea7752566cf680d06c82a2711"],"summary":"Sergio Traversa executive of RELMADA THERAPEUTICS, INC., effective 2026-04-17.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:19f82wda4j18j","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:fabiana-fedeli","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"Fabiana Fedeli seat on RELMADA THERAPEUTICS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1xsilx1yeu3zv","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:committee:relmada-therapeutics-inc:audit-chair-compensation-nominating-and-governance","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"Audit · Chair; Compensation; Nominating and Governance committee of RELMADA THERAPEUTICS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ajjrjtxqlae1","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:fabiana-fedeli","alpha:committee:relmada-therapeutics-inc:audit-chair-compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"Fabiana Fedeli member of Audit · Chair; Compensation; Nominating and Governance, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:5o9ag17ci937","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:john-glasspool","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"John Glasspool seat on RELMADA THERAPEUTICS, INC., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:c6v9931eu3icf","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:committee:relmada-therapeutics-inc:audit-compensation-nominating-and-governance-chair","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"Audit; Compensation; Nominating and Governance · Chair committee of RELMADA THERAPEUTICS, INC., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ourln51f8kgwp","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:john-glasspool","alpha:committee:relmada-therapeutics-inc:audit-compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"John Glasspool member of Audit; Compensation; Nominating and Governance · Chair, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1hhkqxh1ehe7ld","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:charles-j-casamento","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"Charles J. Casamento seat on RELMADA THERAPEUTICS, INC., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1tb7ygt1mzm0rl","event_type":"COMMITTEE_CREATED","effective_at":"2015-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:committee:relmada-therapeutics-inc:audit-compensation-nominating-and-governance","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"Audit; Compensation; Nominating and Governance committee of RELMADA THERAPEUTICS, INC., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1umn4tvt10ymr","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:charles-j-casamento","alpha:committee:relmada-therapeutics-inc:audit-compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"Charles J. Casamento member of Audit; Compensation; Nominating and Governance, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wg2b8l1pv4iyf","event_type":"DIRECTOR_APPOINTED","effective_at":"2012-01-01","detected_at":"2026-10-10T04:46:27.563543+00:00","subject_ids":["alpha:person:sergio-traversa","alpha:company:025d90a8-f941-4960-9a33-3393bec9d167"],"caused_claim_ids":["alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895"],"summary":"Sergio Traversa seat on RELMADA THERAPEUTICS, INC., effective 2012-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:5","subject_id":"alpha:company:025d90a8-f941-4960-9a33-3393bec9d167","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:charles-j-casamento","object_label":"Charles J. Casamento","object_source_name_forms":[],"value":"Charles J. Casamento: Director, Audit; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:charles-j-casamento","name":"Charles J. Casamento"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:27.563543+00:00","sources":[{"id":"alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"RELMADA THERAPEUTICS, INC. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:39:01.198+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:27.563543+00:00","reviewed_at":"2026-10-10T04:46:27.563543+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:6","subject_id":"alpha:company:025d90a8-f941-4960-9a33-3393bec9d167","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:fabiana-fedeli","object_label":"Fabiana Fedeli","object_source_name_forms":[],"value":"Fabiana Fedeli: Director, Audit · Chair; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:fabiana-fedeli","name":"Fabiana Fedeli"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:27.563543+00:00","sources":[{"id":"alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"RELMADA THERAPEUTICS, INC. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:39:01.198+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:27.563543+00:00","reviewed_at":"2026-10-10T04:46:27.563543+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:7","subject_id":"alpha:company:025d90a8-f941-4960-9a33-3393bec9d167","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-glasspool","object_label":"John Glasspool","object_source_name_forms":[],"value":"John Glasspool: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-glasspool","name":"John Glasspool"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:27.563543+00:00","sources":[{"id":"alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"RELMADA THERAPEUTICS, INC. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:39:01.198+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:27.563543+00:00","reviewed_at":"2026-10-10T04:46:27.563543+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:8","subject_id":"alpha:company:025d90a8-f941-4960-9a33-3393bec9d167","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sergio-traversa","object_label":"Sergio Traversa","object_source_name_forms":[],"value":"Sergio Traversa: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sergio-traversa","name":"Sergio Traversa"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2012-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2012-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:27.563543+00:00","sources":[{"id":"alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"RELMADA THERAPEUTICS, INC. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:39:01.198+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17","effective_from":"2012-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:27.563543+00:00","reviewed_at":"2026-10-10T04:46:27.563543+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:9","subject_id":"alpha:company:025d90a8-f941-4960-9a33-3393bec9d167","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:charles-ence","object_label":"Charles Ence","object_source_name_forms":[],"value":"Charles Ence: Chief Accounting and Compliance Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:charles-ence","name":"Charles Ence"},"title":"Chief Accounting and Compliance Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-17","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-17","valid_to":null,"recorded_at":"2026-10-10T04:46:27.563543+00:00","sources":[{"id":"alpha:projection-evidence:document:da10177ac844caba4a7ef1adc8517579bb4f447c23e96a99b23e87d9745ab222","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RLMD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17T00:00:00+00:00","retrieved_at":"2026-05-16T07:41:34.169577+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17T00:00:00+00:00","effective_from":"2026-04-17","effective_until":null,"observed_at":"2026-10-10T04:46:27.563543+00:00","reviewed_at":"2026-10-10T04:46:27.563543+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:10","subject_id":"alpha:company:025d90a8-f941-4960-9a33-3393bec9d167","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:maged-shenouda","object_label":"Maged Shenouda","object_source_name_forms":[],"value":"Maged Shenouda: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:maged-shenouda","name":"Maged Shenouda"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-17","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-17","valid_to":null,"recorded_at":"2026-10-10T04:46:27.563543+00:00","sources":[{"id":"alpha:projection-evidence:document:dd640bb3c5618fe2124057cc303ea5743926d4c5c17312f35d8d833b97db09fa","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RLMD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17T00:00:00+00:00","retrieved_at":"2026-05-16T07:41:33.718863+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17T00:00:00+00:00","effective_from":"2026-04-17","effective_until":null,"observed_at":"2026-10-10T04:46:27.563543+00:00","reviewed_at":"2026-10-10T04:46:27.563543+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:11","subject_id":"alpha:company:025d90a8-f941-4960-9a33-3393bec9d167","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:paul-kelly","object_label":"Paul Kelly","object_source_name_forms":[],"value":"Paul Kelly: Chief Operating Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:paul-kelly","name":"Paul Kelly"},"title":"Chief Operating Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-17","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-17","valid_to":null,"recorded_at":"2026-10-10T04:46:27.563543+00:00","sources":[{"id":"alpha:projection-evidence:document:9e778f6380b0cfe1a78b89f06f2795aa611d6032b15bc830298cbc9784ac5727","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RLMD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17T00:00:00+00:00","retrieved_at":"2026-05-16T07:41:34.635303+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17T00:00:00+00:00","effective_from":"2026-04-17","effective_until":null,"observed_at":"2026-10-10T04:46:27.563543+00:00","reviewed_at":"2026-10-10T04:46:27.563543+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:12","subject_id":"alpha:company:025d90a8-f941-4960-9a33-3393bec9d167","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sergio-traversa","object_label":"Sergio Traversa","object_source_name_forms":[],"value":"Sergio Traversa: Chief Executive Officer, and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sergio-traversa","name":"Sergio Traversa"},"title":"Chief Executive Officer, and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-17","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-17","valid_to":null,"recorded_at":"2026-10-10T04:46:27.563543+00:00","sources":[{"id":"alpha:projection-evidence:document:83d65013329955c9526ec0a0893e4c83a77ef3aea7752566cf680d06c82a2711","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RLMD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17T00:00:00+00:00","retrieved_at":"2026-05-16T07:41:33.23683+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-17T00:00:00+00:00","effective_from":"2026-04-17","effective_until":null,"observed_at":"2026-10-10T04:46:27.563543+00:00","reviewed_at":"2026-10-10T04:46:27.563543+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"RELMADA THERAPEUTICS, INC. DEF 14A 2026-04-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17","retrieved_at":"2026-04-24T23:39:01.198+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:da10177ac844caba4a7ef1adc8517579bb4f447c23e96a99b23e87d9745ab222","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RLMD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17T00:00:00+00:00","retrieved_at":"2026-05-16T07:41:34.169577+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:dd640bb3c5618fe2124057cc303ea5743926d4c5c17312f35d8d833b97db09fa","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RLMD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17T00:00:00+00:00","retrieved_at":"2026-05-16T07:41:33.718863+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9e778f6380b0cfe1a78b89f06f2795aa611d6032b15bc830298cbc9784ac5727","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RLMD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17T00:00:00+00:00","retrieved_at":"2026-05-16T07:41:34.635303+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:83d65013329955c9526ec0a0893e4c83a77ef3aea7752566cf680d06c82a2711","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RLMD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm","source_date":"2026-04-17T00:00:00+00:00","retrieved_at":"2026-05-16T07:41:33.23683+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.832,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.892,"cross_source_agreement":0.75,"temporal_completeness":0.471},"diagnostics":{"published_claims":24,"factual_claims":24,"claims_with_linked_evidence":24,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":17,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-10T04:46:27.563543+00:00","observed_at":"2026-10-10T04:46:27.563543+00:00","reviewed_at":"2026-10-10T04:46:27.563543+00:00","verified_at":"2026-10-10T04:46:27.563543+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":24,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/relmada-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}